| Similar Articles |
|---|
 |
The Motley Fool
September 5, 2008
Brian Orelli |
The Right Formula in Any Economy Babies have to eat, so nutritional supplement maker Martek Biosciences is still thriving.   |
The Motley Fool
June 8, 2005
T.G. Wolf |
Popping Martek's Bubble An abundance of algae, used to make the DHA and ARA in baby formula, weighs on this biosciences company. Investors may want to exercise caution here. |
The Motley Fool
September 7, 2006
Brian Lawler |
Where's the Love for Martek? What could explain a company reporting a 78% increase in quarterly revenues, yet also being the biggest percentage loser of the day on the Nasdaq? Answer: Guidance for the fourth quarter that is well below what analysts were expecting. |
The Motley Fool
June 7, 2006
Brian Gorman |
Martek's Formula for Success Dependence on one customer could spell trouble for this nutritional supplement maker. Investors, take note. |
Nutra Solutions
September 1, 2005 |
Delivering DHA Martek DHA is a vegetarian source of DHA with a ready-made market of moms who know the importance of DHA for brain and eye development. |
BusinessWeek
August 30, 2004
Gene G. Marcial |
Martek: Bringing Up Baby Shares of the baby food maker's stock, at 70 in May, fell to 45 in July when worries rose that it might fail to meet demand. The stock is now at 51, as supplies keep rising. |
The Motley Fool
September 6, 2007
Markos Kaminis |
The Roller Coaster That Is Martek Martek BioSciences, producer of DHA fatty acid, continues its up-and-down pattern. Most recently, the stock prices collapsed after Q3 reports when the company found itself carrying excess capacity. Long-term investors, this may be a good time to buy. |
The Motley Fool
September 22, 2006
Brian Lawler |
The Truth About Dietary Supplements The real issue here is not about one possibly corrupt supplement company -- it's about customers not knowing that the U.S. supplement industry isn't regulated the way pharmaceutical companies are. |
The Motley Fool
January 4, 2011
Seth Jayson |
Should You Get Out of Martek Biosciences Before Next Quarter? For the last fully reported fiscal quarter, Martek Biosciences' year-over-year revenue grew 36%, and its AR grew 57%. That's a yellow flag. |
The Motley Fool
June 30, 2004
Phil Wohl |
General Mills Needs Its Wheaties Fourth-quarter earnings are as expected, but the company warns for fiscal 2005. |
Nutra Solutions
May 1, 2006
Julia Gallo-Torres |
R&D Applications: Live Long, and Healthy Enzymotec, provides bio-functional ingredients that can be used in infant foods, functional foods, clinical nutrition and dietary supplements. |
The Motley Fool
December 21, 2010
Brian D. Pacampara |
Martek Biosciences Shares Skyrocketed: What You Need to Know Martek Biosciences saw its shares soar a staggering 35% in early Tuesday trading after Dutch vitamin giant Royal DSM NV said it will bid $1.09 billion for the company. |
The Motley Fool
July 29, 2004
Phil Wohl |
Whole Foods Trips The largest natural and organic foods retailer is trying to sustain growth. The shares of this exciting company are a little overweight, but attractive. |
The Motley Fool
February 25, 2008
Brian Lawler |
Supplements Take a Hit The leaders of the company which produces the supplement Enzyte are convicted of deceptive advertising. It was allowed to do this because the FDA takes the opposite approach to supplement producers that it does for pharmaceutical drugmakers. |
The Motley Fool
September 13, 2006
Tim Beyers |
Who's Buying Now? Sometimes insiders are buying for all the right reasons. Who's buying now? Human Genome Sciences... Martek Biosciences... MasterCard... Pinnacle Entertainment... U-Store-It Trust... |
Financial Advisor
July 6, 2010 |
Innovative Alternative Strategies Conference Supplement 2010 The supplement to the Innovative Alternative Strategies Conference is attached. |
The Motley Fool
January 17, 2007
Alyce Lomax |
The Best Retail Stock for 2007: Whole Foods Market Don't give up on Whole Foods. Its share price got trimmed by 40% last year, but it seems clear that 2007 will be a significant year, at the very least in terms of building on the company's strong foundations for long term gain. |
Prepared Foods
October 1, 2005
Elizabeth Mannie |
Fish (Oil) Tales Omega-3 fatty acids, particularly DHA and EPA found in fish oil, soon are likely to be seen as one of the biggest nutrients for fortification of food products in the U.S., second only to calcium. |
The Motley Fool
October 19, 2006
Brian Lawler |
Where Are The Earnings, USANA? Sales grew, but earnings didn't, compared to last year's third quarter. How much longer will the good times will last for supplement companies? It's anyone's guess, so USANA needs to start growing earnings faster and exhibiting some economies of scale. |
Prepared Foods
January 2008 |
Hitting the Shelves A collision of flavors... World-saving cookies... Tuning the body... Portion-controlled veggies... Trends around the globe... |
Food Processing
October 2007 |
Nutrition Beyond the Trends: Get Smart with Omegas Omega 3 oils were already simmering as a trend a dozen years ago. Now, newer sources and applications technology are driving interest in these healthful fats even higher. |
The Motley Fool
February 12, 2004
Rick Aristotle Munarriz |
Ace in the Whole Foods Whole Foods earns a shiny organic apple for its desk with excellent company performance at a time when other grocers are faltering. |
Food Processing
June 2012
Mark Anthony |
Is Algae DHA As Healthy as Fish Oil DHA? A review of research earlier this year found mostly good news in this vegetarian source. |
Food Processing
September 2009
Diane Toops |
(O)mega Opportunities arise with Omega Fatty Acids Higher-income, health-conscious shoppers are seeking foods with omega fatty acids. |
Prepared Foods
February 4, 2006
Marcia A. Wade |
Loose Lipids While every oil has its "strengths and weaknesses," what matters most is how a particular type of oil affects the Nutrition Facts panel. |
The Motley Fool
February 17, 2010
Alyce Lomax |
Whole Foods Prevails The organic grocer defies a difficult environment in its fiscal first quarter. |
